These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 10362120

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Infrequent p53 mutations in arsenic-related skin lesions.
    Castrén K, Ranki A, Welsh JA, Vähäkangas KH.
    Oncol Res; 1998; 10(9):475-82. PubMed ID: 10223623
    [Abstract] [Full Text] [Related]

  • 3. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
    Hughes JH, Robinson RA.
    Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772
    [Abstract] [Full Text] [Related]

  • 4. p53 gene mutations in human epithelial skin cancers.
    Molès JP, Moyret C, Guillot B, Jeanteur P, Guilhou JJ, Theillet C, Basset-Sèguin N.
    Oncogene; 1993 Mar; 8(3):583-8. PubMed ID: 8437842
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Analysis of p16 gene mutation, deletion and methylation in patients with arseniasis produced by indoor unventilated-stove coal usage in Guizhou, China.
    Zhang AH, Bin HH, Pan XL, Xi XG.
    J Toxicol Environ Health A; 2007 Jun; 70(11):970-5. PubMed ID: 17479413
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A study of mitochondrial DNA D-loop mutations and p53 status in nonmelanoma skin cancer.
    Prior SL, Griffiths AP, Lewis PD.
    Br J Dermatol; 2009 Nov; 161(5):1067-71. PubMed ID: 19624548
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease.
    Hida Y, Kubo Y, Murao K, Arase S.
    Arch Dermatol Res; 2007 May; 299(2):103-6. PubMed ID: 17180656
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
    Park HR, Min SK, Cho HD, Kim KH, Shin HS, Park YE.
    J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
    [Abstract] [Full Text] [Related]

  • 18. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
    Bolshakov S, Walker CM, Strom SS, Selvan MS, Clayman GL, El-Naggar A, Lippman SM, Kripke ML, Ananthaswamy HN.
    Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
    Saglam O, Salama M, Meier F, Chaffins M, Ma C, Ormsby A, Lee M.
    Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.